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Abstract
In the process of the planned and systematic education of patients/families, it is extremely important to identify patients’ 
health problems as well as their needs and expectations. The objective of this study was to determine the relationship between 
functional disability, health problems and perceived educational needs in people with systemic sclerosis (SSc). This was a 
cross-sectional analytic study conducted in six rheumatology centers in Poland. Functional disability was measured using 
HAQ-DI, and the magnitude of other health problems (pain, fatigue, intestinal problems, breathing problems, Raynaud’s 
phenomenon, finger ulcerations) was measured using 0–100 mm visual analogue scales. The educational needs were meas-
ured using the Polish version of the Educational Needs Assessment Tool (Pol-ENAT). Spearman’s correlation coefficient 
(rs) was used to report associations. The sample comprised 140 patients, 125 (89.28%) were women. They had a mean (SD) 
age of 54 (14.23) and disease duration of 11 (10.27) years. The median (IQR) HAQ-DI was 1.12 (0.62–1.62) and mean 
ENAT score was 71.54 (SD 27.72). Patients needed to know more about the disease process, self-help measures and man-
aging pain. All health problems had significant correlations with the overall educational needs, pain, functional disability 
and fatigue having the highest rs = 0.359, p < 0.0001; rs = 0.314, p < 0.001 and rs = 0.270, p = 0.001, respectively. Health 
problems in people with SSc are associated with considerable educational needs; therefore, health professionals should take 
this into account when planning patient education. Group interventions should consider providing patient education related 
to disease process as a minimum.
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Introduction
Systemic sclerosis (SSc), scleroderma, is a complex hetero-
geneous chronic condition with an autoimmune background, 
characterized by progressive fibrosis of the skin and internal 
organs, which lead to their failure, as well as abnormal renal 
morphology and dysfunction of blood vessels [1]. Sclero-
derma is considered a rare disease affecting between 31 and 
88 per 1,000,000 population in the UK [2] and around 250 
per 1,000,000 in Poland [3]. Women are 3–5 times more 
likely to be affected than men.
Several clinical subsets exist and differ by skin involve-
ment, frequency and the extent of organ involvement, 
the presence of antinuclear antibodies, the nature of 
microvascular changes as well as the disease’s course and 
prognosis. The most common is limited systemic sclerosis 
(approximately 2/3 of patients) and the other subset, diffuse 
systemic sclerosis is more severe and affects approximately 
1/3 of all patients with SSc. Due to its multisystem involve-
ment, the disease has severe physical and psychosocial 
impact affecting the patients’ quality of life [4].
Management of SSc includes patient education aimed at 
preparing patients and their carers or family for self-man-
agement. Given the complexity of the disease, potential 
complications and treatments [5], self-management of the 
SSc will involve more than just self-care. This is likely to 
include focusing on the disease and its needs, knowledge 
and engagement with healthcare and managing life with 
the chronic illness [6]. Needs-based patient education is the 
means through which effective self-management could be 
achieved [7].
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Patient education is an integral component of the compre-
hensive management of rheumatic diseases and this is con-
sistent with the recommendations of the European League 
Against Rheumatism [7] and the diagnostic and therapeu-
tic standards of the Polish Society for Rheumatology [8]. 
Patient education can be defined as a planned interactive 
learning process designed to support and enable people to 
manage their life with a rheumatic disease and optimise 
their health and well-being [7]. It comprises all educational 
activities provided for patients, including aspects of thera-
peutic education, health education and health promotion [9]. 
Its benefits include improved knowledge about the disease 
[9], increased self-efficacy [10], acceptance and motivation 
to take actions that positively influence the health of the 
patient.
It is important to identify the needs and expectations of 
the patient, as well as their health problems and difficulties, 
especially in their physical, psychological, and social func-
tioning. The success of the complex therapeutic treatment 
requires that the patient with SSc is actively engaged in the 
process of treatment and in the monitoring of the pharma-
cological therapy’s effects [5, 8]. The patient should know 
the drugs’ adverse effects as well as be able to observe the 
internal organs’ symptoms and any signs of exacerbations. 
It is of utter importance to prevent the complications and 
life-threatening states, such as scleroderma renal crisis or 
pulmonary hypertension.
The interdisciplinary rheumatology team needs to ensure 
that targeted, needs-based patient education is given to all 
patients [7]. The educational needs assessment tool (ENAT) 
was developed to enable systematic assessment of educa-
tional needs of people with rheumatic disease [11]. This tool 
has now been validated in Poland for use in SSc [12]. The 
aim of this study was to determine the relationship between 
functional disability, health problems and perceived educa-
tional needs of people with SSc. This would help understand 
the factors associated with patient education and determine 
possible areas for targeting patient education, thus optimize 
its effects. Targeted education can bring about better func-
tioning, coping and improved quality of life of people with 
SSc.
Methods
Design
This was a cross-sectional analytic study conducted at rheu-
matology and internal medicine departments of six hospitals 
in Poland. Ethical approvals were obtained from the Bioeth-
ics Committee of the Medical University of Bialystok (R 
I-002/87/2015).
Patients and measures
Patients were selected using random sampling and the 
inclusion criteria were a diagnosis of SSc, based on the 
ACR/EULAR 2013 criteria [1], and age ≥ 18 years. Exclu-
sion criteria were minimal, only age below 18 years. The 
patients signed informed consent to participate in the 
study. Researchers from the centers explained the purpose 
of the study and the patients completed the questionnaires 
unaided.
We used the following measures: (i) The Polish version 
of the educational needs assessment tool (Pol-ENAT) [12] 
to assess educational needs (ii) health assessment ques-
tionnaire disability index (HAQ-DI) (website: http://www.
mapi-resea rch-inst.com) [13, 14] to assess functional dis-
ability and (iii) 0–100 mm visual analogue scales (VAS) 
to assess pain severity, fatigue severity and severity of 
the following health problems: disease severity, intestinal 
problems, breathing problems, Raynaud’s phenomenon 
and fingers’ ulceration.
The ENAT is a questionnaire designed to help clinicians 
identify priority educational needs and help addressing 
them in a timely manner [11, 15]. The ENAT was first 
developed for patients with arthritis [15] and was later 
validated in other rheumatic diseases including SSc [11]. 
The cross-cultural validation into Polish is reported else-
where [12]. The tool comprises 29 items, which are for-
matted as a 0–4 rating scales (0 = not at all important, 1 = a 
little important, 2 = fairly important, 3 = very important, 
4 = extremely important). The items are then grouped 
into seven sub-scales: managing pain (0–24), movement 
(0–20), feelings (0–16), disease process (0–28), treatments 
(0–28), self-care measures (0–24) and support systems 
(0–16). The ENAT domain scores are Rasch-transformed 
(using raw-to-linear score conversion charts—published 
elsewhere [12]) to enable their use in parametric analyses. 
Adding up all the transformed domain scores gives the 
total ENAT score, which is an estimate of the patient’s 
educational, needs (range = 0–156) [11, 12]. The HAQ-
DI is a validated generic measure of physical functioning 
combining eight domains (dressing and grooming, arising, 
eating, walking, hygiene, reach, grip and other activities) 
[13]. Responses to each item range from zero (no diffi-
culty) to three (unable to do). The total score ranges from 
0 to 3. Data collection were carried out from June 2014 to 
December 2014.
Data analysis
All data were analysed using PQStat v.1.4.2 software. 
The raw scores from the Pol-ENAT which are ordinal 
Rheumatology International 
1 3
in nature were transformed into interval level measures 
using calibrated conversion tables (published elsewhere 
[12]) before being combined with other data and subjected 
to parametric analyses. All data were then summarised 
descriptively using means, standard deviations (interval 
level data) and medians and interquartile ranges (ordinal-
level data) as appropriate. As each ENAT domain has dif-
ferent score range, each ENAT domain scores was “nor-
malized” by dividing by the maximum possible score (%) 
to enable comparisons across domains. For the inferential 
statistics, we tested the null hypothesis of no correlation 
between educational needs and patient health problems 
(including disability). Spearman’s correlation coefficient 
rs is reported together with p-values, where rs of 0–0.19, 
0.2–0.39, 0.40–0.59, 0.6–0.79 and 0.8–1 represented 
very weak, weak, moderate, strong and very strong cor-
relations, respectively. HAQ-DI and VAS scores are pre-
sented as median with interquartile range. The associa-
tion between personal characteristics (gender, age, disease 
duration), and educational background were tested across 
all measures. Kruskal–Wallis (H) test was used to assess 
differences and across patient subgroups.
Results
The sample comprised 140 patients (Bialystok 60, Lublin 20, 
Warsaw 19, Poznan 17, Sopot 13 and Srem 11) the majority 
(125, 89.28%) of whom were women and their mean age 
was 54.14 (SD 14.23) years. Those with limited SSc were 
83 (59.28%) and diffuse SSc 57 (40.72%).
Table 1 presents patients’ characteristics, health prob-
lems and educational needs. The educational needs are 
summarized as ENAT domain scores and the degree of 
need is expressed as average score divided by the maxi-
mum possible score for that domain. Of all patient-
reported health problems (0–100  mm VAS), fatigue, 
Raynaud’s phenomenon and disease severity scored the 
highest. Most patients had ‘moderate to severe’ disability. 
The median HAQ-DI score was 1.12 (IQR: 0.62–1.62). 
Table 1  Patient characteristics, 
health problems and educational 
needs
IQR interquartile range, Q25 first quartile (25th percentile), Q75 third quartile (75th percentile)
a ENAT domains have different number of items, therefore, the degree of need is determined by average 
score divided by the maximum possible score for that domain
Variables studied (score range) Mean (SD) except 
where stated
Degree of  needa Median (IQR: Q25–Q75)
Age 54.14 (14.23) 56 (46–64.25)
Disease duration 10.89 (10.27) 8 (3–15)
Gender—number of women (%) 125 (89.28)
Educational background
 Basic—number (%) 16 (11.43)
 Secondary—number (%) 56 (40.00)
 Professional—number (%) 32 (22.86)
 Higher education—number (%) 36 (25.71)
HAQ-DI (0–3) 1.12 (0.62–1.62)
Pain-VAS (0–100) 37.5 (15–61.25)
Fatigue-VAS (0–100) 50 (25–70)
Disease severity (0–100) 50 (25–65)
Raynaud’s attacks (0–100) 50 (10–70)
Intestinal problems (0–100) 7.5 (0–45)
Breathing problems (0–100) 20 (0–50)
Finger ulceration (0–100) 0 (0–30)
Educational needs (Pol-ENAT)
 Managing pain (0–24) 12.40 (5.61) 0.52
 Movement (0–20) 8.88 (5.13) 0.44
 Feelings (0–16) 8.05 (4.41) 0.50
 Disease process (0–28) 15.02 (5.79) 0.54
 Treatments (0–28) 7.73 (5.62) 0.25
 Self-help (0–24) 12.51 (6.47) 0.52
 Support (0–16) 6.95 (3.54) 0.43
 Total ENAT (0–156) 71.54 (27.72)
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Most of the respondents (n = 120, 85.71%) wanted to get 
information to help them manage their SSc and 60.71% 
(n = 85) wanted to know ‘everything’. The mean ENAT 
score was 71.54 (SD 27.72). The highest educational needs 
were related to the following domains: disease process, 
self-help and managing pain.
Table 2 summarises the correlations between health prob-
lems (including functional disability, pain and fatigue) and 
educational needs (ENAT domain scores and total score). 
Pain and functional disability had the largest degree of asso-
ciation with patients’ educational needs, especially in the 
‘movements’ domain; rs = 0.462 and 0.408 for functional 
disability and pain, respectively. All health problems had 
significant correlations with patients’ overall educational 
needs. There were ‘weak correlations’ between educational 
needs and health problems except for breathing problems, 
which had ‘very weak correlation’.
Table 3 summarises the correlations between personal 
characteristics (age, gender and disease duration) and health 
problems. Age and disease duration were largely correlated 
with patient-reported health problems. The exceptions to 
this were finger ulceration and Raynaud’s attacks. Dis-
ease duration was associated with disability, pain, disease 
severity, intestinal and breathing problems; the largest 
association being due to the difference between 0 and 5 years 
and > 20 years groups especially on disability (rs = 0.312, 
p < 0.001) and pain (rs = 0.308, P < 0.001). See Table 3.
Table 4 presents differences in health problems by educa-
tional background. The differences were significant for pain, 
fatigue, disease severity and Raynaud’s attacks. Patients with 
higher education had better (lower) scores than those with 
only primary education or vocational education.
Discussion
The main aim of this study was to determine the relationship 
between functional disability, health problems and perceived 
educational needs of people with SSc. We sought to test the 
hypothesis that increasing health problems would be associ-
ated with higher educational needs. Our results have shown 
that health problems especially, pain, disability, fatigue and 
disease severity, are associated with patients’ educational 
needs. The higher the magnitude of the health problems 
means the greater the need for patient education. This means 
those patients with higher health problems are most likely 
to benefit from patient education. Although all patients with 
a long-term condition will need patient education at some 
Table 2  Correlation between health problems and specific domains of educational needs
Bold values indicate the level of significance p ≤ 0.05
rs Spearman’s correlation coefficient where values of 0–0.19 represent very weak, 0.2–0.39 weak, 0.40–0.59 moderate, 0.6–0.79 strong and 
0.8–1.0 very strong correlations
Health prob-
lems (score 
range)
Pol-ENAT domains Total
Managing 
pain
Movement Feelings Disease 
process
Treatments Self-help 
measures
Support 
systems
Pol-ENAT
rs (p-value) rs (p-value) rs (p-value) rs (p-value) rs(p-value) rs (p-value) rs (p-value) rs (p-value)
HAQ DI 
(0–3)
0.166 (0.050) 0.462 
(< 0.0001)
0.140 (0.100) 0.254 (0.002) 0.270 (0.001) 0.108 (0.203) 0.137 (0.108) 0.314 (< 0.001)
Pain-VAS 
(0–100)
0.307 (< 0.001) 0.408 
(< 0.0001)
0.178 (0.036) 0.297 (< 0.001) 0.225 (0.008) 0.171 (0.043) 0.198 (0.019) 0.359 
(< 0.0001)
Fatigue-VAS 
(0–100)
0.215 (0.011) 0.249 (0.003) 0.160 (0.060) 0.186 (0.028) 0.227 (0.007) 0.117 (0.170) 0.178 (0.036) 0.270 (0.001)
Disease 
Severity 
(0–100)
0.144 (0.090) 0.352 
(< 0.0001)
0.168 (0.047) 0.190 (0.024) 0.229 (0.006) 0.076 (0.371) 0.186 (0.027) 0.272 (0.001)
Raynaud’s 
attacks 
(0–100)
0.152 (0.073) 0.277 (< 0.001) 0.292(< 0.001) 0.163 (0.055) 0.102 (0.231) 0.126 (0.138) 0.171 (0.044) 0.236 (0.005)
Intestinal 
problems 
(0–100)
0.233 (0.006) 0.213 (0.012) 0.232 (0.006) 0.153 (0.071) 0.097 (0.253) 0.163 (0.055) 0.036 (0.672) 0.215 (0.011)
Breathing 
problems 
(0–100)
0.188 (0.026) 0.192 (0.023) 0.239 (0.004) 0.149 (0.080) 0.140 (0.098) 0.055 (0.522) 0.043 (0.616) 0.197 (0.020)
Finger ulcera-
tion (0–100)
0.085 (0.319) 0.277 (< 0.001) 0.250 (0.003) 0.116 (0.172) 0.160 (0.059) 0.097 (0.254) 0.242 (0.004) 0.237 (0.005)
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point in their disease trajectory, identifying those with the 
highest needs may help to prioritise resources and activities.
While the age of patients and duration of their illness 
was significantly associated with the severity of their health 
problems, there were no direct correlations between educa-
tional needs and age or disease duration. In other rheumatic 
diseases, educational needs have been shown to be associ-
ated with personal characteristics such as age, gender and 
disease duration [16–18]. In rheumatoid arthritis (RA) for 
example, lower age and shorter disease duration is associ-
ated with higher educational needs [18] and this has also 
been shown in systemic lupus erythematosus, where younger 
age and shorter disease duration were each associated with 
higher level of educational needs particularly the emotional/
feelings domain [16]. In SSc, however, such relationship has 
not been evident [19]. One plausible explanation for this is 
that in SSc, educational needs may be more related to the 
health problems than they are to age and disease duration; 
and as such, targeting the need or health problems may be 
more important than targeting age groups for example.
Patients in this study had ‘moderate to severe’ functional 
disability which is consistent with other findings in SSc 
[20]. Pain and fatigue may be important determinants of 
functional disability in patients with limited and diffused 
forms of the disease [21, 22] and these were also high scor-
ing health problems in our study. The highest educational 
needs were in the domains of disease process, self-help 
and managing pain. In most rheumatic diseases, educa-
tion about disease process has consistently been among the 
highest scoring ENAT domains [16–19], and there may be a 
strong message to health practitioners to expect and prepare 
patient education resources about disease process as a mini-
mum standard, especially when planning group educational 
interventions. Within the context of multidisciplinary team 
care, patients with SSc that are identified as having severe 
disability or high levels of fatigue or pain could be referred 
for patient education as a standard and this will help ensure 
an appropriate follow-up/care is in place.
This study has three main limitations. First, although the 
sample was taken from six sites, it was hospital-based and 
may not be representative of the SSc population in Poland. 
As SSc is a rare condition, recruiting from multiple sites 
is necessary and yet it is difficult to ensure representation. 
Second, since this was a survey, selection bias cannot be 
excluded as most motivated patients are more likely to return 
the questionnaires i.e. self-selection bias. Third, as this was 
a non-randomised cross-sectional study the relationship 
between variables represent association rather than causality.
Conclusion
Functional disability, pain, fatigue and other health problems 
in people with SSc are associated with considerable edu-
cational needs, therefore, health professionals should take 
this into account when planning patient education for this 
group of patients. While individualised patient education 
should target patients’ educational needs, group interven-
tions should consider providing patient education related to 
disease process as a minimum provision. Using tools such 
as the ENAT for assessing educational needs may help in 
to accurately identify patients’ needs, problems and prefer-
ences, which is necessary for delivering needs-based patient 
education.
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